StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KMTR.JK$220.00-3.51%
Fair $220.00+0.0%

KMTR.JK

PT Kirana Megatara Tbk

Consumer Cyclical / Auto PartsJakarta

$220.00

-8.00 (-3.51%)

Fairly Valued+0.0%Fair Value $220.00Fund rank 22/100 · Data gapFallback financials|
SA 27/D
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-70.8B · quality 33.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 10/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

27/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · KMTR.JKLocal privado en este navegador · PT Kirana Megatara Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.81T

P/E

30.8x

↑

EV/EBITDA

7.4x

↓

ROE

8.7%

↑

Gross Margin

7.7%

↓

Debt/Equity

0.96

↑
52-Week Range$220
$200$410

TradingView lightweight chart

KMTR.JK price, volumen y niveles de valoración

Último $220.00Periodo -74.3%
Fair value: $220.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+3.8%

FCF CAGR

+6.7%

FCF margin

9.9%

FCF / Net income

6.87x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $12.83T · net income $185.11B · FCF $1.27T

2022-FY → 2025-FY

Gross margin

7.7%+1.7% pts

Operating margin

4.5%+1.9% pts

Net margin

1.4%+1.7% pts

FCF margin

9.9%+0.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$12827.19B$12827.19B$11258.88B$9139.55B$11484.29B
Net Income$185.11B$185.11B$194.84B$-70.40B$-23.83B
EBITDA$454.30B$454.30B$544.87B$131.95B$124.54B
EPS——23.72-8.57-2.90
Gross Margin7.7%7.7%9.4%5.5%6.0%
Operating Margin4.5%4.5%5.4%1.5%2.7%
Net Margin1.4%1.4%1.7%-0.8%-0.2%
Balance Sheet
Debt/Equity0.960.961.631.341.38
Current Ratio1.351.35———
Cash Flow
Free Cash Flow$1272.53B$1272.53B$-477.11B$-70.76B$1048.21B
Returns
ROE8.7%8.7%9.8%-3.8%-1.3%
Valuation
P/E30.7730.7713.58——
EV/EBITDA7.437.4310.0434.5935.24
P/B0.840.841.331.271.15
Growth & Yield
Revenue Growth13.9%13.9%23.2%-20.4%—
EPS Growth——376.8%-195.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -19.1%

Total return

-19.1%

Start / end P/E

n/dx → n/dx

EPS bridge

23.72 → n/d

Residual

-19.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-19.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.